# Pr.JOY vs Neuro65/AOCN2024

The clearest difference is iOS requirement: Pr.JOY at 13.0 against Neuro65/AOCN2024's 15.5. On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

## The numbers

| Metric | Pr.JOY | Neuro65/AOCN2024 |
| --- | --- | --- |
| Price | Free | Free |
| Positive reviews | 16.7% of reviews | — |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Monthly | — |
| Monetization | Free | — |
| Size | 114 MB | 26 MB |
| Requires iOS | **13.0** | 15.5 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 12+ |
| Developer | [Drjoy](https://appshunter.io/developer/933087764) | [Japanese Society of Neurology](https://appshunter.io/developer/1382465034) |

## What reviewers say

### Pr.JOY

[App page](https://appshunter.io/ios/app/prjoy/id1471077547)

This is an exclusive, invitation-only social network for the medical industry. It facilitates scheduling meetings with doctors, pharmacists, and clients, and enables real-time communication with healthcare professionals. Users can also create groups for article sharing and discussions.

**Highlights:** Meeting scheduling, Real-time chat with healthcare professionals, Group creation for article sharing, Calendar synchronization, Web conferencing for meetings

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### Neuro65/AOCN2024

[App page](https://appshunter.io/ios/app/neuro65aocn2024/id6497567555)

**In-app purchases:** none


## Frequently asked questions

### Is Pr.JOY free?

Pr.JOY is free to download, with no in-app purchases.

### Is Neuro65/AOCN2024 free?

Neuro65/AOCN2024 is free to download, with no in-app purchases.

### Do Pr.JOY or Neuro65/AOCN2024 have ads?

Neither Pr.JOY nor Neuro65/AOCN2024 shows ads.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*